Provenienza dei contatti di primo grado di Barry J. Byrne
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL.
6
| Subsidiary | Biotechnology | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Barry J. Byrne tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Investment Managers | Analyst-Equity | |
The Johns Hopkins University | College/University | Doctorate Degree | |
University of Karachi | College/University | Undergraduate Degree | |
EDITAS MEDICINE, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
DICE THER | Biotechnology | Director/Board Member | |
JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
TYRA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Xenikos BV
Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Investment Managers | Director/Board Member | |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Princeton University | College/University | Undergraduate Degree | |
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Analyst-Equity | |
Mailman School of Public Health | College/University | Director/Board Member | |
KBI Services, Inc.
KBI Services, Inc. Medical/Nursing ServicesHealth Services KBI Services, Inc. provides women healthcare and fertility services. It offers in vitro fertilization services. The company was founded by Joanne Schneider and Gina Bartasi in April 2018 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Freenome Holdings, Inc.
Freenome Holdings, Inc. BiotechnologyHealth Technology Freenome Holdings, Inc. engages in the development of multiomics platform for early cancer detection. It develops simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a machine learning feedback loop between care and science. The company was founded by Charles Roberts, Riley Ennis, and Gabriel Otte and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Corporate Officer/Principal | |
MEIRAGTX HOLDINGS PLC | Biotechnology | Director/Board Member | |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
SYNLOGIC, INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 20 |
Paesi Bassi | 2 |
Francia | 2 |
Regno Unito | 2 |
Settori
Health Technology | 12 |
Finance | 7 |
Consumer Services | 5 |
Health Services | 3 |
Posizioni
Director/Board Member | 17 |
Independent Dir/Board Member | 4 |
Undergraduate Degree | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Analyst-Equity | 2 |
Contatti più connessi
Insiders | |
---|---|
Ellen Hukkelhoven | 11 |
Jake Simson | 11 |
Noaman Akhtar | 4 |
Manuela Corti | 1 |
Philip Johnson | 1 |
Benjamin Lund | 1 |
- Borsa valori
- Insiders
- Barry J. Byrne
- Connessioni Società